X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
transcatheter arterial chemoembolization (2466) 2466
humans (1865) 1865
hepatocellular carcinoma (1752) 1752
index medicus (1401) 1401
male (1307) 1307
liver neoplasms - therapy (1219) 1219
female (1214) 1214
middle aged (1143) 1143
carcinoma, hepatocellular - therapy (1123) 1123
aged (1011) 1011
transarterial chemoembolization (808) 808
treatment outcome (806) 806
oncology (793) 793
radiology, nuclear medicine & medical imaging (766) 766
adult (691) 691
liver neoplasms - pathology (679) 679
gastroenterology & hepatology (670) 670
liver cancer (659) 659
cancer (628) 628
hepatoma (621) 621
carcinoma, hepatocellular - pathology (615) 615
embolization (592) 592
survival (555) 555
chemoembolization, therapeutic - methods (546) 546
retrospective studies (512) 512
liver (509) 509
radiofrequency ablation (497) 497
care and treatment (481) 481
chemoembolization, therapeutic (479) 479
liver neoplasms - mortality (472) 472
prognosis (455) 455
carcinoma, hepatocellular - mortality (449) 449
surgery (432) 432
transcatheter arterial embolization (422) 422
aged, 80 and over (419) 419
therapy (394) 394
survival rate (375) 375
medicine & public health (358) 358
tumors (357) 357
chemotherapy (346) 346
chemoembolization (344) 344
hepatocellular-carcinoma (342) 342
liver neoplasms - diagnostic imaging (314) 314
combined modality therapy (303) 303
carcinoma, hepatocellular - diagnostic imaging (280) 280
management (279) 279
tomography, x-ray computed (271) 271
chemoembolization, therapeutic - adverse effects (270) 270
liver neoplasms - drug therapy (265) 265
liver neoplasms - surgery (264) 264
radiotherapy (264) 264
percutaneous ethanol injection (254) 254
cirrhosis (248) 248
antineoplastic agents - administration & dosage (247) 247
hepatectomy (241) 241
carcinoma, hepatocellular - surgery (238) 238
randomized controlled trial (236) 236
carcinoma, hepatocellular - drug therapy (234) 234
risk factors (227) 227
survival analysis (227) 227
patients (220) 220
neoplasm staging (214) 214
resection (213) 213
efficacy (205) 205
sorafenib (205) 205
hepatic resection (204) 204
recurrence (202) 202
analysis (197) 197
follow-up studies (197) 197
tace (196) 196
ablation (192) 192
imaging / radiology (187) 187
unresectable hepatocellular-carcinoma (187) 187
time factors (183) 183
animals (180) 180
magnetic resonance imaging (177) 177
radiology (174) 174
liver-transplantation (167) 167
iodized oil (164) 164
randomized controlled-trial (164) 164
abridged index medicus (162) 162
liver neoplasms - radiotherapy (161) 161
liver neoplasms - diagnosis (159) 159
ultrasound (158) 158
carcinoma, hepatocellular - radiotherapy (152) 152
microspheres (150) 150
digestive system diseases (149) 149
angiography (148) 148
health aspects (148) 148
metastasis (148) 148
contrast media (147) 147
antineoplastic agents - therapeutic use (145) 145
cisplatin (145) 145
embolization, therapeutic - methods (143) 143
prospective studies (143) 143
nuclear medicine (142) 142
carcinoma, hepatocellular - diagnosis (140) 140
doxorubicin (137) 137
doxorubicin - administration & dosage (137) 137
hcc (136) 136
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3038) 3038
Japanese (56) 56
Korean (46) 46
German (38) 38
French (25) 25
Chinese (20) 20
Spanish (5) 5
Italian (3) 3
Polish (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
American Journal of Dermatopathology, ISSN 0193-1091, 02/2018, Volume 40, Issue 2, pp. e25 - e27
Journal Article
by Cai, R and Song, RF and Pang, PF and Yan, Y and Liao, YF and Zhou, CL and Wang, SC and Zhou, XL and Wang, HP and Zhang, HY and Sun, HH and Ma, HQ
BMC CANCER, ISSN 1471-2407, 11/2017, Volume 17, Issue 1, pp. 714 - 9
Background: Many studies have combined sorafenib with transcatheter arterial chemoembolization (TACE) to treat patients with advanced hepatocellular carcinoma... 
THERAPY | MANAGEMENT | ONCOLOGY | Sorafenib | TACE | TRANSARTERIAL CHEMOEMBOLIZATION | Advanced hepatocellular carcinoma | Clinical trial | HCC | RECURRENCE | Transcatheter arterial chemoembolization | ENDOTHELIAL GROWTH-FACTOR | Care and treatment | Hepatoma | Comparative analysis | Patient outcomes | Cancer
Journal Article
Journal Article
Acta Biomaterialia, ISSN 1742-7061, 09/2016, Volume 41, pp. 253 - 263
Journal Article
Journal Article